Whereas most primary tumor samples contained a distinct plasma cell infiltrate, CD19+CD20−CD38high cells were very rare in metastatic samples (31.7% vs. 3.7% of CD45+CD19+ cells, p<0,005, Fig. 4C). The gene discussed is CD19; the disease is neoplasm.